Cerebrospinal fluid 20-HETE is associated with delayed cerebral ischemia and poor outcomes after aneurysmal subarachnoid hemorrhage.
about
Spreading Depression, Spreading Depolarizations, and the Cerebral VasculatureCyclooxygenase- and cytochrome P450-derived eicosanoids in strokeCombined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition.Role of soluble epoxide hydrolase in age-related vascular cognitive decline.Current practice in neuropsychological outcome reporting after aneurysmal subarachnoid haemorrhage.Genetic markers in the EET metabolic pathway are associated with outcomes in patients with aneurysmal subarachnoid hemorrhageCall for uniform neuropsychological assessment after aneurysmal subarachnoid hemorrhage: Swiss recommendations.A role of the sodium pump in spreading ischemia in rats.Plasma Estrogen Levels Are Associated With Severity of Injury and Outcomes After Aneurysmal Subarachnoid Hemorrhage.20-HETE is associated with unfavorable outcomes in subarachnoid hemorrhage patientsProtective role of p450 epoxyeicosanoids in subarachnoid hemorrhage.Endothelin-1 and endothelin receptor gene variants and their association with negative outcomes following aneurysmal subarachnoid hemorrhageControversies and evolving new mechanisms in subarachnoid hemorrhage.Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic TargetEicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.Cytochrome P450 eicosanoids in cerebrovascular function and disease.Cerebral artery myogenic reactivity: The next frontier in developing effective interventions for subarachnoid hemorrhage.Hyperbaric oxygenation and 20-hydroxyeicosatetreanoic acid inhibition reduce stroke volume in female diabetic Sprague-Dawley rats.Targeted metabolomics reveals altered oxylipin profiles in plasma of mild cognitive impairment patients
P2860
Q28264417-2EDC9520-795C-4676-BC5C-1AE8687351D3Q28271874-CF0E5EC2-2C65-4F5D-9906-522FA8A2D239Q34428950-75829ED6-3F20-4AFD-8751-E59AEE3F8AB2Q34622501-37375E54-4E66-471B-9538-F187119B41FCQ34866884-F1C1FD49-155C-48C2-BAE2-B9260DB1AF4CQ35591243-0BD6D189-6435-40DE-9B73-E7E9A19DB4BDQ35693058-EA4AE785-FBD8-4C66-8D34-92901C9B1DD2Q35963546-03831B26-6DB6-48D8-A2F9-52AC40D0D8D1Q35984368-227E3319-F9C4-47F1-B3F2-A37A9F0C1332Q36267499-7C193C8F-2F7E-44E1-A3BE-3739D0166B51Q36483681-4A6B8E65-5068-4262-987C-8CCD3DA3DF2EQ37136254-610CE142-09EC-4592-A647-AF223BC5F17AQ37652820-0855FE80-1B58-45E0-A836-6921E56C17E7Q37731230-C72FF1DE-F233-43CC-B4B5-7A8F28C72BEFQ37995534-4A9859B0-0FA0-4CA5-A558-F6E66A927B5FQ39319956-74942F5A-A6AF-4CD0-A076-90F11C65FE8CQ47285240-5096F2A2-539F-4347-99B7-96E362EB6CBCQ47630318-F071C7C1-ED06-43A7-BC51-87FAA0F19DB9Q59273884-666D7463-F11C-4ADC-9023-4E7BD8504885
P2860
Cerebrospinal fluid 20-HETE is associated with delayed cerebral ischemia and poor outcomes after aneurysmal subarachnoid hemorrhage.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Cerebrospinal fluid 20-HETE is ...... ysmal subarachnoid hemorrhage.
@ast
Cerebrospinal fluid 20-HETE is ...... ysmal subarachnoid hemorrhage.
@en
type
label
Cerebrospinal fluid 20-HETE is ...... ysmal subarachnoid hemorrhage.
@ast
Cerebrospinal fluid 20-HETE is ...... ysmal subarachnoid hemorrhage.
@en
prefLabel
Cerebrospinal fluid 20-HETE is ...... ysmal subarachnoid hemorrhage.
@ast
Cerebrospinal fluid 20-HETE is ...... ysmal subarachnoid hemorrhage.
@en
P2093
P2860
P1433
P1476
Cerebrospinal fluid 20-HETE is ...... ysmal subarachnoid hemorrhage.
@en
P2093
Bhavani P Thampatty
Catherine Bender
Chie-Wen J Kuo
Elizabeth A Crago
Jeffrey Balzer
Michael Horowitz
Paula R Sherwood
Samuel M Poloyac
P2860
P304
P356
10.1161/STROKEAHA.110.605816
P407
P577
2011-05-26T00:00:00Z